These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4177267)

  • 21. Natural immunity to measles, rubella and mumps among Spanish children in the pre-vaccination era.
    Arroyo M; Alia JM; Mateos ML; Carrasco JL; Ballesteros F; Lardinois R
    Int J Epidemiol; 1986 Mar; 15(1):95-100. PubMed ID: 3957548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factors affecting the effectiveness of vaccination with live measles vaccine].
    Redechkina ZP
    Pediatriia; 1971 Jan; 50(1):63-5. PubMed ID: 4102318
    [No Abstract]   [Full Text] [Related]  

  • 23. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
    Poethko-Müller C; Mankertz A
    PLoS One; 2012; 7(8):e42867. PubMed ID: 22880124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of measles in the United States.
    Barkin RM; Conrad JL
    J Infect Dis; 1973 Sep; 128(3):353-6. PubMed ID: 4728691
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and therapeutic aspects of measles in the past 15 years].
    Gavrilă I; Josan R; Pîrvu C; Serban I; Cucu A; Marina M; Iepureanu A
    Microbiol Parazitol Epidemiol (Bucur); 1973; 18(4):339-44. PubMed ID: 4135398
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM
    An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measles, mumps and rubella vaccination status of school beginners in Munich].
    Markuzzi A; Schlipköter U; Weitkunat R; Meyer G
    Soz Praventivmed; 1997; 42(3):133-43. PubMed ID: 9334085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
    Amela C; Pachón I; de Ory F
    Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.
    Nicoara C; Zäch K; Trachsel D; Germann D; Matter L
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):868-71. PubMed ID: 10548578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinico-epidemiologic effectiveness of the prophylactic activity of 3, 1.5 and 1 ml of gamma-globulin in foci of mixed measles and influenzal infections].
    Ignat'eva GV; Shatrov II; Mastiukova IuN; Khrometskaia TM; Sareava NT; Nesterova TP
    Vopr Virusol; 1968; 13(4):444-8. PubMed ID: 4178462
    [No Abstract]   [Full Text] [Related]  

  • 33. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
    Chaiwarith R; Praparattanapan J; Nuket K; Kotarathitithum W; Supparatpinyo K
    BMC Infect Dis; 2016 Apr; 16():190. PubMed ID: 27138005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
    Socan M; Berginc N
    Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The economic effectiveness of using live measles vaccine].
    Popov VF; Ivannikov IuG; Luk'ianov IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Aug; 49(8):37-9. PubMed ID: 4117530
    [No Abstract]   [Full Text] [Related]  

  • 36. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. I. Efficacy and analysis of vaccine failures.
    Fescharek R; Quast U; Maass G; Merkle W; Schwarz S
    Vaccine; 1990 Aug; 8(4):333-6. PubMed ID: 2396472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity of learning disorders: prevalence and familial transmission.
    Landerl K; Moll K
    J Child Psychol Psychiatry; 2010 Mar; 51(3):287-94. PubMed ID: 19788550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
    Mossong J; Putz L; Schneider F
    Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaccination and morbidity in Basel school-children (measles, mumps, rubella, chickenpox, cytomegalic inclusion disease)].
    Bächlin A; Berger-Hernandez R; Just M
    Soz Praventivmed; 1978 Aug; 23(4):253-6. PubMed ID: 212901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.